Patrick J. Stiff

26.7k citations
254 papers · 8.9k · 5 hit papers · h-index 47

Impact in

  • Hematology top 0.2%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research
    • Multiple Myeloma Research and Treatments
  • Oncology top 0.5%
    • Viral-associated cancers and disorders
    • CAR-T cell therapy research

Papers in

    • Hematopoietic Stem Cell Transplantation 84
    • Acute Myeloid Leukemia Research 36
    • Multiple Myeloma Research and Treatments 33
    • Viral-associated cancers and disorders 24
    • CAR-T cell therapy research 22

Patrick J. Stiff

241 papers receiving 8.6k citations

Patrick J. Stiff's Hit Papers

Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial 2015 · 500 citations
5000+7+14Years since publication200400600

Peers

Patrick J. Stiff
Comparison fields: 5 of 126
  • Hematology 3.1k
  • Oncology 3.6k
  • Pathology and Forensic Medicine 2.2k
  • Genetics 1.1k
  • Otorhinolaryngology 316
Replace William Bensinger with:
William Bensinger United States
Donna Reece Canada
Auayporn Nademanee United States
Gary Spitzer United States
D. Crowther United Kingdom
Christos Emmanouilides United States
Wim L.J. van Putten Netherlands
Michele Ghielmini Switzerland
Anthony S. Stein United States
Brad Pohlman United States
Patrick J. Stiff relative to William Bensinger United States William Bensinger's profile →
Citations per field
00.5×3.9×
William Bensinger · 1×
Citations per year

Countries citing papers authored by Patrick J. Stiff

Since Specialization
Citations

This map shows the geographic impact of Patrick J. Stiff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick J. Stiff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick J. Stiff more than expected).

Fields of papers citing papers by Patrick J. Stiff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick J. Stiff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick J. Stiff. The network helps show where Patrick J. Stiff may publish in the future.

Co-authors

The 25 scholars most cited alongside Patrick J. Stiff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick J. Stiff Line = papers co-authored together Patrick J. Stiff links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 254 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers
Hit paper breakdown →
2004668
2
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma
Hit paper breakdown →
2009593
3
Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma
Hit paper breakdown →
2009527
4
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial
Hit paper breakdown →
2015500
5
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia
Hit paper breakdown →
2013481
6 2010240
7 2013232
8 2006223
9 2012207
10 2006171
11 2010167
12 2018165
13 2006126
14 2001106
15 2013105
16 2006104
17 200899
18 200795
19 201094
20 201393

About Patrick J. Stiff

Patrick J. Stiff is a scholar working on Hematology, Oncology, Pathology and Forensic Medicine, Genetics and Immunology, having authored 254 papers that have together received 8.9k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (84 papers), Lymphoma Diagnosis and Treatment (61 papers), Acute Myeloid Leukemia Research (36 papers), Multiple Myeloma Research and Treatments (33 papers), Viral-associated cancers and disorders (24 papers), Chronic Lymphocytic Leukemia Research (24 papers), CAR-T cell therapy research (22 papers) and Acute Lymphoblastic Leukemia research (20 papers). The work is most often cited by research in Hematology (3.1k citations), Oncology (3.6k citations), Pathology and Forensic Medicine (2.2k citations), Genetics (1.1k citations) and Otorhinolaryngology (316 citations). Patrick J. Stiff has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Auayporn Nademanee, Ivana N. Micallef, John F. DiPersio, Richard T. Maziarz, Gary Bridger, Tawee Tanvetyanon, John M. McCarty, Brian J. Bolwell, Richard I. Fisher and Gary Calandra. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology, Bone Marrow Transplantation and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact